Company intelligence / Profile preview

Farmabios

Gropello Cairoli, Pavia, Italyaxplora.com ↗

Ownership: Private
Employees: ~93
Development stage: Commercial

Overview

Farmabios specializes in the development and manufacture of active pharmaceutical ingredients—especially steroids and high-potency substances—for global pharmaceutical companies. It offers both nonsterile and sterile APIs as well as custom synthesis services. The company has decades-long expertise in steroid chemistry and supports clients from process development through commercial supply. It was acquired by PharmaZell Group and merged into the new entity Axplora.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeSteroidsSemi-synthetic cephalosporinsHigh potent substancesAntibioticsPeptides
Industry: Contract Manufacturing Organization

Partnerships

Not specifically disclosed; works with global pharma companies as contract manufacturer/custom synthesis partner.

Beyond the preview

Go deeper on Farmabios.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Farmabios.

Explore the full profile